Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/21930607
Conclusion of this study
The determinants of poor CD4(+) T-cell recovery following cART require further investigation.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
Body systems related to this study
 Immune System |
